First Trust Advisors’s Mirum Pharmaceuticals MIRM Stock Holding History

First Trust Advisors’s Portfolio MIRM Stock Details MIRM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.9M	Sell	136,141 -15,131	-10%	-$1.52M	0.01%	1015
2026 Q1	$14M	Buy	151,272 +13,572	+10%	+$1.28M	0.01%	979
2025 Q4	$10.9M	Sell	137,700 -6,548	-5%	-$470K	0.01%	1068
2025 Q3	$10.6M	Buy	144,248 +14,454	+11%	+$919K	0.01%	1075
2025 Q2	$6.61M	Buy	129,794 +160	+0.1%	+$7.12K	0.01%	1232
2025 Q1	$5.84M	Sell	129,634 -4,547	-3%	-$214K	0.01%	1243
2024 Q4	$5.55M	Sell	134,181 -12,230	-8%	-$510K	﹤0.01%	1305
2024 Q3	$5.71M	Buy	146,411 +119,024	+435%	+$4.75M	0.01%	1263
2024 Q2	$936K	Buy	27,387 +16,122	+143%	+$423K	﹤0.01%	1972
2024 Q1	$283K	Buy	+11,265	New	+$310K	﹤0.01%	2239

Other funds holding MIRM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Trust Advisors's MIRM Position: Q2 2026 in Review

First Trust Advisors reduced its Mirum Pharmaceuticals (MIRM) stake by 10% in Q2 2026, selling an estimated $1.52M and leaving 136,141 shares worth $15.9M. The position accounts for 0.01% of the portfolio, ranked #1015.

First Trust Advisors first reported a position in MIRM in Q1 2024 and has held it in 10 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

First Trust Advisors held 136,141 shares of Mirum Pharmaceuticals worth $15.9M as of Q2 2026.
First Trust Advisors sold 15,131 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.52M.
Mirum Pharmaceuticals made up 0.01% of First Trust Advisors's portfolio in Q2 2026, its #1015 holding.
First Trust Advisors first reported a position in Mirum Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.